OBJECTIVE: To see whether changes in prescribing of oral antibacterials in Northern Ireland show the need for a community antibiotics policy. DESIGN: Analysis of prescribing totals for several oral antibiotics obtained retrospectively from the prescription pricing bureau for the years 1983-7. SETTING: Audit of anti-infective prescribing in general practice in Northern Ireland over five years. MAIN OUTCOME MEASURE: Respective usage of agents defined as "common" and "occasional" in 1983. RESULTS: There was a gradual decrease in the relative use of common agents from 82% of the total in 1983 to 77% in 1987 together with a complementary increase in the use of occasional agents from 5% to 10%. Pronounced changes were noted in the use of amoxycillin, ampicillin, erythromycin, minocycline, doxycycline, and amoxycillin-clavulanic acid. CONCLUSION: Though this survey found reasonably conservative prescribing, the trend towards increased use of occasional agents has both clinical and cost implications which could be addressed by the use of a prescribing formulary.
OBJECTIVE: To see whether changes in prescribing of oral antibacterials in Northern Ireland show the need for a community antibiotics policy. DESIGN: Analysis of prescribing totals for several oral antibiotics obtained retrospectively from the prescription pricing bureau for the years 1983-7. SETTING: Audit of anti-infective prescribing in general practice in Northern Ireland over five years. MAIN OUTCOME MEASURE: Respective usage of agents defined as "common" and "occasional" in 1983. RESULTS: There was a gradual decrease in the relative use of common agents from 82% of the total in 1983 to 77% in 1987 together with a complementary increase in the use of occasional agents from 5% to 10%. Pronounced changes were noted in the use of amoxycillin, ampicillin, erythromycin, minocycline, doxycycline, and amoxycillin-clavulanic acid. CONCLUSION: Though this survey found reasonably conservative prescribing, the trend towards increased use of occasional agents has both clinical and cost implications which could be addressed by the use of a prescribing formulary.
Authors: R M Banda; A S Muula; G R Gwaza; D C Namarika; K C Ng'oma; F E Chintolo; H Yamakazi; A P Muyco Journal: Malawi Med J Date: 2001-09 Impact factor: 0.875